Cancer immunotherapy

Cancer immunotherapy—the use of the immune system to treat cancer—is one of the most promising therapies to emerge since the development of chemotherapy in the twentieth century. Harnessing the body's own innate defense mechanisms to attack cancer cells has demonstrated potential for developing treatments that are not only more efficacious (including long-lasting remissions and progression-free survival rates), but also more precise. Importantly, increased precision may reduce the toxicity that is often experienced with current pharmaceutical interventions. Different immunotherapeutic approaches, ranging from activating the patient's own immune response to attack cancer cells to neutralizing mechanisms designed to regulate and suppress patient's immune systems, are increasingly implemented in the regimen of oncology clinical care with positive results.











For more details : https://bacteriology.infectiousconferences.com/

Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv...
Read more

How bacteria grow in Anaerobic environment?

Bacteria that grow in Oxygen deficit condition: Scientists have uncovered a mechanism by which bacterial cells in crowded, anaerobic environment access oxygen for energy generation which ensures survival of the cell. The finding could clarify how a few microscopic organisms, for example, Pseudomonas aeruginosa, can flourish in oxygen-poor conditions like biofilms and resist antibiotics. P. aeruginosa biofilm diseases are a main source of death for individuals suffering from cystic fibrosis, a hereditary condition that affects the lungs and the digestive system. Microscopic organisms rarely live by themselves as single-celled organisms. Most rather develop in networks, utilizing the strength of numbers to form a biofilm with tissue-like properties similar to a scaffold that serves to strengthen the community , making it up to 1,000 times more resistant to most antibiotics. Every individual cell should without anyone else extract electrons from food that are then transp...
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m...
Read more